Unitedhealth Group Inc

NYSE: UNH
$575.00
-$2.07 (-0.4%)
Closing Price on September 20, 2024

UNH Articles

Tenet Healthcare watched its shares make a handy gain early on Thursday after The Wall Street Journal announced that it was exploring the possibility of a sale.
DuPont, General Electric, Pfizer, and UnitedHealth were the leading DJIA gainers Thursday.
Boeing's 50% share price increase so far in 2017 has driven the DJIA to a gain of more than 11% for the year to date. And there appears to be little reason for Boeing's run to end anytime soon.
The DJIA was headed for a nearly flat close Thursday, with Pfizer and UnitedHealth offsetting share price declines at Apple and DuPont.
Chevron, American Express, Travelers, and UnitedHealth pulled the DJIA higher on Friday.
Stocks were indicated marginally higher on Thursday after the European Central Bank statement remained quite dovish. The major equity indexes all remain just under all-time highs. Even though this...
DuPont, Cisco, Boeing, and UnitedHealth led the DJIA to a nice gain on Wednesday.
UnitedHealth's second-quarter earnings beat the consensus estimate for profits and met the estimate for revenues. Investors reacted indifferently to the report.
24/7 Wall St. has put together a preview of General Electric, Microsoft and other Dow Jones Industrial Average companies scheduled to report their quarterly results this coming week.
Intel, Boeing, JPMorgan, and UnitedHealth kept the DJIA in the green Wednesday.
Home Depot, Goldman Sachs, Wal-Mart, and UnitedHealth were the leading losers among the Dow 30 stocks on Friday.
With a Federal Reserve rate hike decision, investors have to keep in mind what to think of the stock market heading into the rest of this summer and what to expect for the rest of 2017.
The top analyst upgrades, downgrades and other research calls from Wednesday include Check Point Software, Coca-Cola, Kraft Heinz, PepsiCo and UnitedHealth.
UnitedHealth, Goldman Sachs, General Electric, and McDonald's led the DJIA higher Thursday.
Credit Suisse has raised its price targets for select managed care organizations but remains neutral to cautious on hospital stocks.